Software as a Medical Service, or SaMS, Takes Spotlight in New CMS Proposal
Clinical labs have until Aug. 31 to submit public comments about the anticipated changes
Already a member? Log in here
CMS-lir
Subscribe today for access to
Articles and Reports
New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
CDC Issues ICD-10-CM Coding Guidance for Coronavirus Encounters
...
Already a member? Log in here
Reimbursement: Congress Calls on Insurers to Cover Coronavirus Testing without Charging Patients
...
Already a member? Log in here
Lab industry leaders meet with White House on COVID-19 testing
...
Already a member? Log in here
Two commercial labs testing now for COVID-19
...
Already a member? Log in here
CMS Develops Additional Code for Coronavirus Lab Tests
...
Already a member? Log in here
How to Adjust to the April 2018 Medicare Beneficiary Cards
By Sean McSweeney bio
In a press release on May 30, 2017, the Centers for Medicare & Medicaid Services (CMS) commented regarding their fraud prevention initiative program and their planned changes regarding…
Industry Buzz: ACLA Goes for Kill in PAMA Lab Fees Challenge Case
From – Laboratory Industry Report
Attorneys for the American Clinical Laboratory Association asked the federal court for summary judgment in its lawsuit challenging…
Already a member? Log in here
OPPS 2018: Revised Payment Rates & a New ADLT Date of Service Exemption
From – Laboratory Industry Report
With all of the PAMA commotion, CMS’s publication of the 2018 Medicare Hospital and Ambulatory Surgical Outpatient Prospective Payment System (OPPS) final rule has…
Already a member? Log in here
PAMA-Geddon: CMS Slashes 2018 Part B Lab Rates
...
Already a member? Log in here
“Applicable Labs”: The Fly in the PAMA Market-Based Pricing Ointment
From – Laboratory Industry Report
The lab industry has no objection to basing Medicare payments for lab tests on the actual rates charged to payors in the private market. What has the industry so upset is how…
Already a member? Log in here